Member Info for dunk1973

Syn00gold - what was the figure SSH confirmed for the start volume on immediate approval?

I cannot see that figure from the tweet.

Nice that SSH has confirmed start volume on immediate approval that will be available.

Thanks very much for explaining.

Can anyone explain what this means from the RNS.

RD can you expand on what you mean by.

4. Details old payments is a secret but everyone is happy

testing of contacts is not covered by this authorisation”

So what would the remaining Innova tests be used on if not for daily testing.

What a silly post based on the evidence presented about Activ 2.

Sang I am sure I saw a post from you saying you were invested in Tils or were invested.

Please confirm.

Sang can I ask why you invested then if all the above is true.

You paint a very dull picture for Tils to advance further with its pipeline.

Tils seem to be trying everything to get the price higher.

1. Posts good covid data results although a small data set.

2. Announces a Phase 2 covid trial to start soon.

3. Other positive pipeline plans updated.

4. Investor presentations galore.

And still the price is sub 60p.

What will it take to get the price over £1 and then.£2?

I personally believe this is it until Tils move onto a Phase 3 trial. Until there is a sniff of commercialisation this price is going to drift further or see saw between 50p and 70p. Such a shame with all the promises made. This was pumped so much last year by the company and a select few on here, facebook and twitter. Looks like that pumping has damaged the integrity of the company and many don't trust it anymore to rise just on it's own back.

PR is none existent with Tils.

This was always going to IPO with additional shares so not sure why people are suprosed by this.

I believe GC mentioned a listing price of 60p. If that happens I'll be happy with that. Any more and it's a big bonus.

"...and we cannot conclude that nasal Foralumab has a beneficial effect in COVID-19 until larger studies are performed"

This was always going to be the case in a Phase 1 trial with only 39 patients. Not unexpected at all for such results.

Elsol excellently explained in simple terms.

"The options that have been exercised were due to expire in September 2021. Certain of the new ordinary shares have been sold, at a price of 140p, to meet the tax and subscription costs associated with the exercise, with the remaining shares being retained by the directors.'

Duffer did you read the RNS properly?

What is the time frame were news cannot drop now due to these options?

We have been in the Phase 3 Sprinter trial since Feb. 2021.

Polygon 10%
Polar 7.99%

That has to be a sign of confidence.

If any PI's sell at the moment it makes no sense to me. Hold for just a little while longer and reap the rewards

When do you think Stormharbour will complete.

The government want cheap drugs.

Tils would be way too expensive.